Suraksha Diagnostic, a company in the Healthcare Service Provider industry, reported revenue of ₹99 crore and net profit of ₹15 crore for the September 2026 quarter.
Suraksha Diagnostic (NSE: SURAKSHA) closed at ₹311.50 on 20 Nov 2026, up 3.4% over the past year. Its market capitalisation is ₹1,622 crore and it trades at 38.8 times earnings.
Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.